CARVAJAL ALEJANDRA (Chief Legal Officer) sold 16.3% of their position (3.94K shares) of MERSANA THERAPEUTICS, INC. on the open market
Open‑market sale worth $15.3K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/28/2023ACC: 0001104659-23-052984
Officer· Chief Legal Officer
Since Apr 2021
-3.94K
Net shares
Net seller
$15.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
13.25K acquired · 17.19K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+13.25K
Price / share
—
Trade value
—
% of position
120.2%
4/26/2023
11.02K→24.27K
Common Stock
Direct
Shares
−3.94K
Price / share
$3.89
Trade value
$15.34K
% of position
16.3%
4/27/2023
24.27K→20.33K
Total
Net shares
+9.31K
Net value
-$15.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/26/2023 | M · Option Exercise | +13.25K | — | — | 120.2% | 11.02K | 24.27K |
| Common Stock Direct | 4/27/2023 | S · Sale | −3.94K | $3.89 | $15.34K | 16.3% | 24.27K | 20.33K |
| Total | +9.31K | -$15.34K | ||||||
Derivative Transactions1
Restricted stock unit
Direct
Converts to
Common Stock
13.25K shares
Shares
−13.25K
Strike price
Held after
0.00
Exercisable
—
4/26/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted stock unit Direct | Common Stock13.25K shares | 4/26/2023 | M · Option Exercise | −13.25K | — | 0.00 |